Indrayani Biotech 대차 대조표 상태
재무 상태 기준 확인 2/6
Indrayani Biotech has a total shareholder equity of ₹762.7M and total debt of ₹1.1B, which brings its debt-to-equity ratio to 147.5%. Its total assets and total liabilities are ₹2.4B and ₹1.6B respectively. Indrayani Biotech's EBIT is ₹222.1M making its interest coverage ratio 2.2. It has cash and short-term investments of ₹302.5M.
주요 정보
147.5%
부채 비율
₹1.13b
부채
| 이자 보상 비율 | 2.2x |
| 현금 | ₹302.52m |
| 주식 | ₹762.66m |
| 총 부채 | ₹1.59b |
| 총 자산 | ₹2.35b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
재무 상태 분석
단기부채: 526445's short term assets (₹1.4B) exceed its short term liabilities (₹870.7M).
장기 부채: 526445's short term assets (₹1.4B) exceed its long term liabilities (₹716.9M).
부채 대 자본 내역 및 분석
부채 수준: 526445's net debt to equity ratio (107.9%) is considered high.
부채 감소: Insufficient data to determine if 526445's debt to equity ratio has reduced over the past 5 years.
부채 범위: 526445's operating cash flow is negative, therefore debt is not well covered.
이자 보장: 526445's interest payments on its debt are not well covered by EBIT (2.2x coverage).